Understanding Knee Osteoarthritis and Why Treatment Choice Matters

Knee osteoarthritis is a common condition that causes pain, stiffness and reduced mobility, often making everyday activities difficult and affecting overall quality of life. Choosing the right treatment is crucial—not only to ease symptoms but also to help people maintain their independence. This article compares two popular injectable treatments: Arthrosamid and traditional hyaluronic acid injections. We will explore how Arthrosamid overcomes some of the drawbacks of short-lived viscosupplementation, focusing on its longer-lasting effects, patient convenience, and innovative way of working within the joint. The insights of orthopaedic expert Professor Paul Lee, alongside the dedicated care at MSK Doctors, highlight how advances in treatment offer new hope. Remember, this article is designed to inform and should not replace personalised advice from your healthcare professional.

The Limits of Traditional Hyaluronic Acid Injections

Hyaluronic acid injections have been used for many years to manage knee osteoarthritis. They work by supplementing the joint’s natural lubricating fluid, helping to cushion the knee and temporarily relieve pain. But the main issue with this treatment is that its effects don’t last long—patients often require repeated injections. Furthermore, results can vary widely, leaving some people frustrated by inconsistent relief. A comprehensive review explains that “patients with mild morphological alterations responded better to therapy” but also emphasises that “the characteristics of responders must be more precisely defined.” In other words, while hyaluronic acid can help certain patients, it doesn’t always provide the durable, dependable benefit many seek. This highlights the need for treatments that offer more lasting and predictable outcomes.

Arthrosamid: A Longer-Lasting Solution with Synovial Integration

Arthrosamid offers a fresh approach to treating knee osteoarthritis. It uses a polyacrylamide hydrogel that integrates directly with the synovial membrane—the thin lining inside the joint responsible for producing fluid and maintaining joint health. This integration means Arthrosamid stays in the joint much longer, providing sustained relief from pain and stiffness. Clinical studies show that many patients experience benefits from just a single session, reducing the need for frequent injections. This longer-lasting effect not only improves symptoms but also makes life easier by cutting down visits to the clinic. This innovative method represents a step forward compared to traditional hyaluronic acid therapies.

Putting Patients First: Convenience and Consistency in Managing Chronic Osteoarthritis

One of Arthrosamid’s biggest advantages is how it centres on the patient experience. Being usually administered in a single session, it offers consistent and reliable symptom relief across different types of patients. For those living with chronic knee osteoarthritis, this means less disruption and greater peace of mind. MSK Doctors provide a supportive environment that encourages patients to explore these advanced treatments safely. Under the guidance of Professor Paul Lee, who champions evidence-based and forward-thinking care, patients are empowered to make informed choices that suit their lifestyles and health needs.

Making Well-Informed Treatment Decisions with Expert Support

To sum up, Arthrosamid presents clear benefits over traditional hyaluronic acid injections, especially in terms of durability and convenience. While hyaluronic acid still has a role for some patients, those seeking more lasting relief may find Arthrosamid a better fit. The same review also points out that “treatment schedules, at present mainly based on individual clinical experience, need a proper and accepted standardisation,” signalling ongoing efforts to refine and improve care. Ultimately, every patient is different, so treatment decisions must be tailored accordingly. Consulting healthcare professionals, such as the experienced team at MSK Doctors, ensures an expert approach to choosing the right option. For individual medical advice, always speak with a qualified healthcare professional.

References

Abate, M., Pelotti, P., De Amicis, D., Di Iorio, A., Galletti, S., & Salini, V. (2008). Viscosupplementation with Hyaluronic Acid in Hip Osteoarthritis (a review). Upsala Journal of Medical Sciences, 113(3), 261-278. https://doi.org/10.3109/2000-1967-233
Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., & Lee, P. Y. (2025). The impact of patient factors on the minimal clinically important difference of Arthrosamid polyacrylamide hydrogel injection for knee osteoarthritis: A cohort study. Journal of Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.02.648
Gao, H. C. K., Akhtar, M., Creedon, C., Verma, T., & Lee, P. Y. F. (2025). Polyacrylamide hydrogel injections in knee osteoarthritis: A PROMs-based 24 month cohort study. Journal of Clinical Orthopaedics and Trauma. https://doi.org/10.1016/j.jcot.2025.103136